The FDA has chosen Dr Vinay Prasad, a professor at UCSF, to lead its Center for Biologics Evaluation and Research.

Robert F. Kennedy Jr.'s "make America healthy again" is basically Lysenko 2.0. It's come to the NIH and is destroying the crown jewel of US biomedical research with ideology and cronyism.

The collaboration with the German biotech was ramped up a year later to focus on a COVID-19 shot that crashed and burned in a clinical trial, allowing rival vaccines from Pfizer/BioNTech and ...

He s definitely not exclusively Indian says NARAYANI GANESH on the occasion of Rama Navami She finds Rama the Universal Hero vibrantly alive in the consciousness of people across the subcontinent east ...

Endo International is the latest drugmaker to file for chapter 11 bankruptcy protection in connection with opioid litigation in the US, after agreeing a $6 billion deal with creditors that ...

Within Novo Nordisk's comprehensive business update to investors, attention latched onto early data for an oral obesity therapy that outperformed the company’s big-selling GLP-1 agonist Wegovy ...

As December 2022 closed out, Pfizer announced positive top-line results from its phase 3 BENEGENE-2 study evaluating fidanacogene elaparvovec (SPK-9001), its investigational gene therapy for ...

Like most people these days, I have been experimenting with various artificial intelligence (AI) tools this past year. It’s remarkable to see the progress made in the technology compared to only ...

Bristol-Myers Squibb's Celgene unit has clearly been impressed by progress in its four-year-old alliance with Evotec on protein degradation. It's just paid $200 million to extend the partnership ...

He s definitely not exclusively Indian says NARAYANI GANESH on the occasion of Rama Navami She finds Rama the Universal Hero vibrantly alive in the consciousness of people across the subcontinent east ...

ChatGPT has already made waves and has been deployed to write codes, new poems, songs, recipes, and whatnot. Language models that use transformer-based architectures, such as GPT (Generative Pre ...

Novartis’ groundbreaking cancer T-cell therapy CTL019 has won unanimous backing from advisers to the FDA, paving the way for approval in the coming months. There had been concerns that the ...